PPARα activation overcomes fibroinflammatory liver microenvironment-associated anti-PD-1 resistance in hepatocellular carcinoma by mediating GSDME-dependent pyroptosis
Authors:
Open Access
- 6 August 2026
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 9474
Abstract
The fibroinflammatory liver microenvironment (FILM), characterized by collagen-rich stroma and immunosuppressive inflammation, is prevalent in hepatocellular carcinoma (HCC) and correlates with poor response to programmed cell death protein 1 (PD-1) blockade. Here, we show that FILM suppresses gasdermin E (GSDME)-dependent pyroptosis and promotes immune suppression and anti-PD-1 resistance. Mechanistically, FILM-associated cancer-associated fibroblasts recruit and polarize macrophages toward a nitric oxide synthase 2 (NOS2)⁺ inflammatory phenotype. NOS2+ macrophage-derived nitric oxide induces SP1 S-nitrosylation, impairs SP1 binding to the peroxisome proliferator-activated receptor alpha (PPARA) promoter and transcriptionally represses PPARA in HCC cells. PPARα downregulation reduces pyruvate dehydrogenase kinase 4 (PDK4) expression, mitochondrial reactive oxygen species production, caspase-3 activation and GSDME cleavage. Conversely, ligand activation of tumor intrinsic PPARα restores the PDK4–ROS–caspase-3–GSDME axis, enhances dendritic cell and CD8⁺ T cell activation, and sensitizes HCC to anti–PD-1 therapy. The clinically approved PPARα agonist fenofibrate enhances anti-PD-1 efficacy in HCC models in male mice and is associated with improved clinical benefit in a retrospective cohort of patients with HCC. We propose a FILM–NOS2–SP1–PPARα–PDK4 axis that controls pyroptotic immunogenicity and immunotherapy response, supporting PPARα activation as a strategy to overcome FILM-associated immune resistance in HCC.Keywords
Funding Information
- National Natural Science Foundation of China (82503522)
- China Postdoctoral Science Foundation (2025M771964)
This publication has 60 references indexed in Scilit:
- Gasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndromeScience Immunology, 2020
- Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinomaGut, 2019
- Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cellsCell Death & Disease, 2019
- Role of nonresolving inflammation in hepatocellular carcinoma development and progressionnpj Precision Oncology, 2018
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trialThe Lancet, 2017
- Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic/pyroptotic cell deathNature Communications, 2017
- Inflammasome-activated gasdermin D causes pyroptosis by forming membrane poresNature, 2016
- Identification of a Physiologically Relevant Endogenous Ligand for PPARα in LiverCell, 2009
- Sorting out the roles of PPAR in energy metabolism and vascular homeostasisJournal of Clinical Investigation, 2006
- “New” hepatic fat activates PPARα to maintain glucose, lipid, and cholesterol homeostasisCell Metabolism, 2005